Patients with COPD had slightly more major adverse cardiovascular events after initiating single-inhaler triple therapy vs a LABA-ICS inhaler.
With a surge in hMPV cases, many people are wondering what it is, who is at risk, if there is a cure, etc. So, know all about ...